Part of Cardiac & HypertensionCoagulants & Hemostatics
Antifibrinolytics and clotting agents to manage acute hemorrhage and surgical bleeding. All formulations listed are procured under PMBI with verified WHO-GMP standard compliance.
Formulation & Pricing Breakdown6 pricedView details
Coagulants & Hemostatics Formulations (8)
Find Nearby KendraTranexamic Acid Tablets 500 mg
Tranexamic Acid Tablets 500 mg is an evidence-based cardiovascular and hemodynamic pharmaceutical formulation. It acts by modulating vascular smooth muscle tone, autonomic receptors, or fluid-electrolyte balance to manage cardiovascular disease.
Tranexamic Acid Injection 500 mg (100mg per ml)
Tranexamic Acid Injection 500 mg (100mg per ml) is an evidence-based cardiovascular and hemodynamic pharmaceutical formulation. It acts by modulating vascular smooth muscle tone, autonomic receptors, or fluid-electrolyte balance to manage cardiovascular disease.
Tranexamic Acid 500mg + Mefenamic Acid 250mg Tablets
Tranexamic Acid 500mg + Mefenamic Acid 250mg Tablets is an evidence-based cardiovascular and hemodynamic pharmaceutical formulation. It acts by modulating vascular smooth muscle tone, autonomic receptors, or fluid-electrolyte balance to manage cardiovascular disease.
Etamsylate Tablets 500 mg
Etamsylate Tablets 500 mg is an evidence-based cardiovascular and hemodynamic pharmaceutical formulation. It acts by modulating vascular smooth muscle tone, autonomic receptors, or fluid-electrolyte balance to manage cardiovascular disease.
Etamsylate Tablets 250 mg
Etamsylate Tablets 250 mg is an evidence-based cardiovascular and hemodynamic pharmaceutical formulation. It acts by modulating vascular smooth muscle tone, autonomic receptors, or fluid-electrolyte balance to manage cardiovascular disease.
Phytomenadione Injection (Vitamin K1) 1mg per 0.5ml
Phytomenadione Injection (Vitamin K1) 1mg per 0.5ml is an evidence-based cardiovascular and hemodynamic pharmaceutical formulation. It acts by modulating vascular smooth muscle tone, autonomic receptors, or fluid-electrolyte balance to manage cardiovascular disease.
Romiplostim Powder + Solvent for solution for Injection 250mcg per 0.5 vial
Romiplostim is a recombinant thrombopoietin (TPO) receptor agonist "peptibody." It binds to and activates the human TPO receptor (c-Mpl) on megakaryocytes and hematopoietic stem cells via the JAK/STAT pathway, stimulating megakaryocyte proliferation and platelet production. Indicated for immune thrombocytopenia (ITP) in adults refractory to corticosteroids, immunoglobulins, or splenectomy.
Romiplostim Powder + Solvent for solution for Injection 500mcg per vial
Romiplostim is a recombinant thrombopoietin (TPO) receptor agonist "peptibody." It binds to and activates the human TPO receptor (c-Mpl) on megakaryocytes and hematopoietic stem cells via the JAK/STAT pathway, stimulating megakaryocyte proliferation and platelet production. Indicated for immune thrombocytopenia (ITP) in adults refractory to corticosteroids, immunoglobulins, or splenectomy.
Statutory Medical Guidance
All products listed are official PMBI-procured generic drugs and surgical consumables. Schedule H formulations require a valid doctor's prescription for dispensing at Jan Aushadhi Kendras. Always consult a certified healthcare professional before starting or altering any pharmaceutical therapy.